Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that based on preliminary year-end results and subject to year-end closing adjustments,
Maravai LifeSciences Holdings Projects 2024 Revenue Near Midpoint of Guidance
Maravai LifeSciences Holdings said Wednesday it expects to report full-year revenue for 2024 near the midpoint of its most recent outlook. The San Diego company has guided for full-year revenue between $255 million and $265 million. Analysts polled by FactSet had forecast revenue of $259.8 million.
Maravai LifeSciences Restructures Leadership Amid Revenue Update
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your
Hosted on MSN
16h
Sanofi taps Alloy Therapeutics for CNS antisense drug development
As part of the agreement, Sanofi will provide Alloy with upfront license fees and near-term preclinical milestone payments up ...
Contract Pharma
1d
Evonik Partners with ST Pharm to Expand its RNA & Nucleic Acid Therapeutic Services
Increases speed to market for drug developers working on nucleic acid therapeutics.
Future Market Insights
2d
Proteinase K Industry to Reach USD 43.9 Million by 2033, Growing at a Steady CAGR of 4.8%
The global proteinase K market is projected to grow from US$ 27.5 million in 2023 to US$ 43.9 million by 2033, at a CAGR of 4 ...
health.economictimes.indiatimes
6h
HMPV surge in India highlights need for improved diagnostic and preventive measures
Human Metapneumovirus (HMPV) primarily spreads through respiratory secretions from coughing or sneezing, close personal ...
1h
etherna Announces Strategic Multi-Target Collaboration with Dropshot Therapeutics
NV ("etherna"), a technology platform leader pioneering mRNA and lipid-based nanoparticle (LNP) technologies, announces a ...
EuropaWire
7h
Evonik Partners with ST Pharm to Accelerate RNA Therapeutic Development
Evonik has partnered with ST Pharm to enhance its RNA and nucleic acid therapeutic services, combining ST Pharm's expertise in customized nucleic ...
eLife
6d
Opening and closing of a cryptic pocket in VP35 toggles it between two different RNA-binding modes
Department of Biochemistry & Molecular Biophysics, Washington University School of Medicine, St. Louis, USA ...
1d
Quantum-Si’s New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/97.TRc4SPmX.js ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback